Genpact Limited Stock Buy Hold or Sell Recommendation
G Stock | USD 31.70 0.05 0.16% |
Taking into account the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Genpact Limited is 'Strong Hold'. Macroaxis provides Genpact buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Genpact positions. The advice algorithm takes into account all of Genpact's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Genpact's buy or sell advice are summarized below:
Real Value 37.63 | Target Price 42.67 | Hype Value 31.72 | Market Value 31.7 | Naive Value 31.32 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Genpact Limited given historical horizon and risk tolerance towards Genpact. When Macroaxis issues a 'buy' or 'sell' recommendation for Genpact Limited, the advice is generated through an automated system that utilizes algorithms and statistical models.
Genpact |
Execute Genpact Buy or Sell Advice
The Genpact recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genpact Limited. Macroaxis does not own or have any residual interests in Genpact Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genpact's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Genpact Trading Alerts and Improvement Suggestions
Genpact Limited generated a negative expected return over the last 90 days | |
Genpact Limited is unlikely to experience financial distress in the next 2 years | |
Over 99.0% of the company shares are owned by institutional investors | |
On 26th of March 2024 Genpact paid $ 0.1525 per share dividend to its current shareholders | |
Latest headline from finance.yahoo.com: Regulatory Affairs Outsourcing Market To Reach USD 13.1 Billion By 2032 DataHorizzon Research |
Genpact Returns Distribution Density
The distribution of Genpact's historical returns is an attempt to chart the uncertainty of Genpact's future price movements. The chart of the probability distribution of Genpact daily returns describes the distribution of returns around its average expected value. We use Genpact Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genpact returns is essential to provide solid investment advice for Genpact.
Mean Return | -0.15 | Value At Risk | -2.42 | Potential Upside | 2.27 | Standard Deviation | 1.44 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genpact historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Genpact Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Genpact is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genpact Limited backward and forwards among themselves. Genpact's institutional investor refers to the entity that pools money to purchase Genpact's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | First Trust Advisors L.p. | 2023-12-31 | 3.1 M | Westfield Capital Management Company, Lp | 2023-12-31 | 3 M | Geode Capital Management, Llc | 2023-12-31 | 2.9 M | Nordea Investment Mgmt Bank Demark A/s | 2023-12-31 | 2.4 M | Causeway Capital Management Llc | 2023-12-31 | 2.4 M | Dimensional Fund Advisors, Inc. | 2023-12-31 | 2.2 M | Capital Research & Mgmt Co - Division 3 | 2023-12-31 | 2 M | Norges Bank | 2023-12-31 | 2 M | Bank Of New York Mellon Corp | 2023-12-31 | 1.5 M | Fmr Inc | 2023-12-31 | 21.3 M | Blackrock Inc | 2023-12-31 | 17.2 M |
Genpact Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 98.7M | 213.3M | 219.0M | (252.7M) | (63.1M) | (59.9M) | |
Free Cash Flow | 319.1M | 503.9M | 637.0M | 389.3M | 432.0M | 270.0M | |
Depreciation | 128.7M | 159.8M | 167.6M | 129.5M | 92.9M | 107.1M | |
Other Non Cash Items | (26.0M) | 48.4M | (2.6M) | 59.6M | 18.2M | 16.4M | |
Capital Expenditures | 108.8M | 80.4M | 57.2M | 54.4M | 58.8M | 77.3M | |
Net Income | 304.9M | 308.3M | 369.4M | 353.4M | 631.3M | 662.8M | |
End Period Cash Flow | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 472.4M | |
Change To Netincome | 39.8M | 65.4M | 67.4M | 83.8M | 96.3M | 101.1M | |
Dividends Paid | 64.7M | 74.2M | 80.5M | 91.8M | 100.0M | 184.3M | |
Investments | 2.2M | (266.4M) | 142K | (36.6M) | (78.9M) | (75.0M) | |
Change Receivables | (122.0M) | 42.5M | (11.8M) | (112.3M) | (101.1M) | (96.1M) | |
Net Borrowings | 138.7M | 145.4M | 52.1M | (233.0M) | (209.7M) | (199.3M) |
Genpact Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genpact or IT Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genpact's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genpact stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.25 | |
β | Beta against NYSE Composite | 1.07 | |
σ | Overall volatility | 1.43 | |
Ir | Information ratio | -0.17 |
Genpact Volatility Alert
Genpact Limited exhibits very low volatility with skewness of 0.33 and kurtosis of 0.95. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genpact's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genpact's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Genpact Fundamentals Vs Peers
Comparing Genpact's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genpact's direct or indirect competition across all of the common fundamentals between Genpact and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genpact or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genpact's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genpact by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Genpact to competition |
Fundamentals | Genpact | Peer Average |
Return On Equity | 0.31 | -0.31 |
Return On Asset | 0.083 | -0.14 |
Profit Margin | 0.14 % | (1.27) % |
Operating Margin | 0.14 % | (5.51) % |
Current Valuation | 6.64 B | 16.62 B |
Shares Outstanding | 180.33 M | 571.82 M |
Shares Owned By Insiders | 1.00 % | 10.09 % |
Shares Owned By Institutions | 99.00 % | 39.21 % |
Number Of Shares Shorted | 4.42 M | 4.71 M |
Price To Earning | 28.59 X | 28.72 X |
Price To Book | 2.50 X | 9.51 X |
Price To Sales | 1.26 X | 11.42 X |
Revenue | 4.48 B | 9.43 B |
Gross Profit | 1.54 B | 27.38 B |
EBITDA | 630.86 M | 3.9 B |
Net Income | 631.25 M | 570.98 M |
Cash And Equivalents | 646.76 M | 2.7 B |
Cash Per Share | 2.53 X | 5.01 X |
Total Debt | 1.5 B | 5.32 B |
Debt To Equity | 1.04 % | 48.70 % |
Current Ratio | 1.58 X | 2.16 X |
Book Value Per Share | 12.53 X | 1.93 K |
Cash Flow From Operations | 490.81 M | 971.22 M |
Short Ratio | 2.49 X | 4.00 X |
Earnings Per Share | 3.41 X | 3.12 X |
Price To Earnings To Growth | 1.70 X | 4.89 X |
Target Price | 37.0 | |
Number Of Employees | 129.1 K | 18.84 K |
Beta | 1.07 | -0.15 |
Market Capitalization | 5.71 B | 19.03 B |
Total Asset | 4.81 B | 29.47 B |
Retained Earnings | 1.09 B | 9.33 B |
Working Capital | 573.58 M | 1.48 B |
Note: Acquisition by Ajay Agrawal of 4916 shares of Genpact subject to Rule 16b-3 [view details]
Genpact Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genpact . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Genpact Buy or Sell Advice
When is the right time to buy or sell Genpact Limited? Buying financial instruments such as Genpact Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2021 | 2022 | 2023 | 2024 (projected) | Total Stockholder Equity | 1.9B | 1.8B | 2.2B | 1.4B | Total Assets | 5.0B | 4.6B | 4.8B | 3.1B |
Use Investing Ideas to Build Portfolios
In addition to having Genpact in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All Next | Launch |
Check out Genpact Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.311 | Dividend Share 0.55 | Earnings Share 3.41 | Revenue Per Share 24.552 | Quarterly Revenue Growth 0.04 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.